Sage Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
26.03.24
/
50%
€17.20
Target price
26.03.25
€26.71
Performance (%)
-25.49%
Price
26.04.24
€12.78
Summary
This prediction is currently active. The price of Sage Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -25.49%. This prediction currently runs until 26.03.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sage Therapeutics Inc. | 2.037% | 2.037% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target raised by analysts at JPMorgan Chase & Co. from $24.00 to $29.00. They now have an "overweight" rating on the stock.
Ratings data for SAGE provided by MarketBeat